| 國立臺灣師範大學 |
2014-10-27T15:41:56Z |
Atayal Myths
|
黃美金 |
| 國立臺灣師範大學 |
2015-01-29T09:15:36Z |
Atayal Reduplication and Its Interface with Phonology
|
林蕙珊 |
| 慈濟大學 |
2006 |
AtBAG-4在光敏素的訊息傳遞中所扮演的角色
|
鄭凱鴻 |
| 慈濟大學 |
2009 |
AtBAG4在種子及果實發育中所扮演的角色
|
林怡萱 |
| 朝陽科技大學 |
2018-05-31 |
ATC-水中運動椅
|
林志旻 |
| 國立交通大學 |
2014-12-12T02:29:34Z |
ATC公司在中國大陸研發投資之個案研究
|
溫斯成; Szu-Cheng Wen; 王 克 陸; Kehluh Wang |
| 元培科技大學 |
2009-04-24 |
Ate pairing效能改進之研究
|
林志賢 |
| 國立成功大學 |
2014-01 |
Atectonic Expression from Theory to Practice: From Semper's Bekleidung to Empirical Projects
|
Wu, Nan-Wei; Fu, Chao-Ching |
| 臺大學術典藏 |
2021-07-15T05:31:34Z |
Atelocollagen-embedded chondrocyte precursors as a treatment for grade-4 cartilage defects of the femoral condyle: A case series with up to 9-year follow-up
|
Liu, Hwa Chang; Liu, Tzu Shang Thomas; Liu, Yen Liang; JYH-HORNG WANG; Chang, Chih Hung; TIFFANY TING-FANG SHIH; Lin, Feng-Huei |
| 臺大學術典藏 |
2021-12-16T03:41:34Z |
Atelocollagen-Embedded Chondrocyte Precursors as a Treatment for Grade-4 Cartilage Defects of the Femoral Condyle: A Case Series with up to 9-Year Follow-Up
|
Liu, Hwa-Chang; Liu, Tzu-Shang Thomas; Liu, Yen-Liang; Wang, Jyh-Horng; Chang, Chih-Hung; TIFFANY TING-FANG SHIH; Lin, Feng-Huei |
| 臺大學術典藏 |
2022-03-22T08:28:54Z |
Atelocollagen-embedded chondrocyte precursors as a treatment for grade-4 cartilage defects of the femoral condyle: A case series with up to 9-year follow-up
|
Liu H.-C;Liu T.-S.T;Liu Y.-L;Wang J.-H;Chang C.-H;Shih T.T.-F;Lin F.-H.; Liu H.-C; Liu T.-S.T; Liu Y.-L; Wang J.-H; Chang C.-H; Shih T.T.-F; Lin F.-H.; FENG-HUEI LIN |
| 臺大學術典藏 |
2022-03-22T08:32:04Z |
Atelocollagen-embedded chondrocyte precursors as a treatment for grade-4 cartilage defects of the femoral condyle: A case series with up to 9-year follow-up
|
Liu H.-C;Liu T.-S.T;Liu Y.-L;Wang J.-H;Chang C.-H;Shih T.T.-F;Lin F.-H.; Liu H.-C; Liu T.-S.T; Liu Y.-L; Wang J.-H; Chang C.-H; Shih T.T.-F; Lin F.-H.; FENG-HUEI LIN |
| 臺大學術典藏 |
2022-03-22T08:31:57Z |
Atelocollagen-embedded chondrocyte precursors as a treatment for grade-4 cartilage defects of the femoral condyle: A case series with up to 9-year follow-up
|
Liu H.-C;Liu T.-S.T;Liu Y.-L;Wang J.-H;Chang C.-H;Shih T.T.-F;Lin F.-H.; Liu H.-C; Liu T.-S.T; Liu Y.-L; Wang J.-H; Chang C.-H; Shih T.T.-F; Lin F.-H.; FENG-HUEI LIN |
| 臺大學術典藏 |
2021-08-10T03:37:24Z |
Atelocollagen-Embedded Chondrocyte Precursors as a Treatment for Grade-4 Cartilage Defects of the Femoral Condyle: A Case Series with up to 9-Year Follow-Up
|
Liu, Hwa-Chang; Liu, Tzu-Shang Thomas; Liu, Yen-Liang; JYH-HORNG WANG; Chang, Chih-Hung; Shih, Tiffany Ting-Fang; Lin, Feng-Huei |
| 國立臺灣大學 |
1952 |
Atempt to Synthesige 5.6.7.8.2'.3'.4'.5'.6'-Nonahydroxyflavone
|
廖宗凱 |
| 臺北醫學大學 |
1994 |
Atenolol前驅藥之製備研究
|
林友慈 |
| 臺北醫學大學 |
2004 |
Atenolol與Carvedilol於高血壓大白鼠大動脈內皮細胞隙連結之差異性作用
|
李秉穎; Ping-Ying Lee |
| 國立臺灣大學 |
2010 |
AtERF1及AIL7在非生物性逆境耐受性上分別扮演的角色
|
郭瑋文; Kuo, Wei-Wen |
| 朝陽科技大學 |
2022-12-09 |
ATERRA
|
陳奕如;潘妏婷;李岱樺;蔡宜軒;張雨薇;黃沛儒 |
| 臺大學術典藏 |
2021-08-31T06:29:15Z |
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma. Reply
|
Finn R.S.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-14T23:18:53Z |
Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistance
|
Wang, Yulei; Lu, Li Chun; Guan, Yinghui; MING-CHIH HO; Lu, Shan; Spahn, Jessica; CHIH-HUNG HSU |
| 臺大學術典藏 |
2022-02-07T03:29:02Z |
Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistance
|
Wang Y.; Lu L.-C.; Guan Y.; Ho M.-C.; Lu S.; Spahn J.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2021-11-25T02:38:28Z |
Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistance
|
Wang, Yulei; Lu, Li-Chun; Guan, Yinghui; MING-CHIH HO; Lu, Shan; Spahn, Jessica; Hsu, Chih-Hung |
| 國家衛生研究院 |
2021-07 |
Atezolizumab plus bevacizumab for patients with advanced hepatocellular carcinoma and chronic hepatitis B virus infection with high viral load
|
Chen, S;Lai, H;Tsou, H;Shao, Y;Chang, C;Su, T;Liu, T;Chen, L;Cheng, A;Hsu, C |
| 國家衛生研究院 |
2023-06 |
Atezolizumab plus bevacizumab for patients with unresectable hepatocellular carcinoma and high hepatitis B viral load: Focusing on hepatic safety and viral kinetics
|
Chen, SC;Tsou, HHS;Lee, TY;Wang, HW;Chen, YH;Wang, TE;Su, YY;Yang, S;Chiu, CF;Liu, TW;Cheng, AL;Chen, LT;Hsu, C |
